GlassScriptPhysician profile
Babu Manath Eapen
NPI 1700823994
$17,845.69
in general payments reported to CMS, 2019-2025
49 companies · $3,749 in 2025
The $3,749 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,233 · 2020: $1,965 · 2021: $2,241 · 2022: $2,477 · 2023: $2,428 · 2024: $2,751 · 2025: $3,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,729 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,728.79 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,768.18 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $4,573.17 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,644.26 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Genzyme Corporation | $471.74 | 2019-2025 | |
| Mylan Specialty L.P. | $414.70 | 2019-2024 | Yupelri |
| Genentech USA, INC. | $400.02 | 2019-2025 | Xolair, Esbriet |
| Amgen INC. | $385.14 | 2023-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $373.54 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $324.50 | 2022-2025 | Tyvaso, Tyvaso |
| Axsome Therapeutics, INC. | $310.55 | 2023-2025 | Sunosi |
| Gilead Sciences, INC. | $309.49 | 2021-2025 | Veklury |
| Inogen, INC. | $290.43 | 2022-2025 | Inogen |
| Sunovion Pharmaceuticals INC. | $277.87 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $272.43 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $240.37 | 2019-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $232.49 | 2019-2025 | Fisher & Paykel Healthcare |
| Teva Pharmaceuticals USA, INC. | $232.44 | 2020-2023 | Airduo Digihaler |
| Baxter Healthcare | $226.03 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $199.98 | 2024-2025 | |
| Viatris Specialty LLC | $199.73 | 2025 | Yupelri |
| Insmed, INC. | $177.82 | 2024-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $174.13 | 2021-2024 | Smartvest |
| Verona Pharma, INC. | $161.65 | 2025 | Ohtuvayre |
| Philips North America LLC | $143.00 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $133.49 | 2024-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $128.20 | 2019-2025 | Keytruda |
| Vapotherm INC | $82.48 | 2020-2023 | Vapotherm |
| Harmony Biosciences LLC | $75.48 | 2021-2023 | Wakix |
| Mallinckrodt Hospital Products INC. | $63.18 | 2022-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $61.07 | 2021-2025 | |
| Pfizer INC. | $54.43 | 2023 | |
| Grifols USA, LLC | $51.89 | 2020-2025 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $50.70 | 2019-2021 | |
| Csl Behring | $43.57 | 2019-2023 | Kcentra |
| Pulmonx Corporation | $43.38 | 2023-2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Mayne Pharma Commercial LLC | $35.49 | 2020 | |
| Eisai INC. | $22.43 | 2020 | |
| Inspire Medical Systems, INC. | $20.54 | 2024 | Inspire |
| Paratek Pharmaceuticals, INC. | $20.53 | 2023 | Nuzyra |
| Avadel Cns Pharmaceuticals, LLC | $20.17 | 2024 | Lumryz |
| Lilly USA, LLC | $20.08 | 2025 | Zepbound |
| Azurity Pharmaceuticals, INC. | $17.62 | 2023 | Horizant |
| Adma Biomanufacturing LLC | $17.27 | 2021 | |
| Ibsa Pharma INC. | $15.58 | 2022 | |
| Seagen INC. | $15.40 | 2023 | Tukysa |
| Resmed Corp | $13.95 | 2025 | |
| Breathe Technologies, INC. | $11.81 | 2019 | |
| Itamar Medical INC | $11.71 | 2022 | |
| Circassia INC. | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babu Eapen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.